Clinical analysis comparing CR to PR and NR patients with chronic lymphocytic leukemia (CLL) treated with CD19 targeting CAR-T cells observed lower percentages of CD8+PD-1+ for CR patients [137]. Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.